新特能源(01799.HK)斥3億元設合夥企業投資戰略性新興產業
格隆匯9月27日丨新特能源(01799.HK)公佈,於2019年9月27日,本公司(作為有限合夥人)、紅山基金(作為普通合夥人)與烏魯木齊基金管理公司(代表產業引導基金,作為有限合夥人)就成立合夥企業訂立合夥協議。
全體合夥人認繳出資總額為人民幣6.03億元,其中本公司出資3億元,產業引導基金出資3億元。
合夥企業將投資於註冊地在烏魯木齊市內從事高端裝備製造、新材料製造等戰略性新興產業相關企業的股權(包括本集團多晶硅產品質量提升及硅基、鋯基產業鏈延伸等重點項目)。合夥企業的經營範圍為股權投資、投資管理及投資諮詢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.